Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Peel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing novel medicines inspired by nature's evolutionary solutions. The company focuses on creating therapies for challenging diseases, particularly in oncology and inflammatory conditions. By leveraging insights from evolutionary biology, Peel identifies and engineers naturally occurring molecules and mechanisms that have been refined over millennia for potency and specificity. Their innovative approach aims to deliver more effective and safer treatments to patients with significant unmet medical needs, translating the wisdom of nature into breakthrough human therapeutics.
The headquarters serves as the primary center for Peel Therapeutics' research, drug discovery, clinical development programs, and corporate operations.
Situated in the University of Utah Research Park, the headquarters benefits from proximity to leading academic research institutions and a collaborative scientific community.
Peel Therapeutics fosters an innovative, science-driven work environment. The culture emphasizes collaboration, rigorous scientific inquiry, and a shared commitment to translating discoveries into meaningful patient therapies.
Its location within a prominent research park provides access to specialized facilities, potential collaborations, and a skilled talent pool, crucial for a biotech company focused on cutting-edge science.
While Peel Therapeutics is headquartered in the United States, its scientific endeavors and clinical trial activities may involve collaborations with research institutions and clinical sites internationally. The company aims to address global health challenges, particularly in oncology and inflammatory diseases, by advancing its therapies towards worldwide patient access.
421 Wakara Way, Suite 202
Salt Lake City
Utah
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Peel Therapeutics' leadership includes:
Peel Therapeutics has been backed by several prominent investors over the years, including:
As of mid-2024, there have been no major C-suite level executive hires or exits publicly announced by Peel Therapeutics in the last 12 months. The company's leadership team appears stable as it continues to advance its research and clinical programs.
Discover the tools Peel Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Common email formats for companies like Peel Therapeutics often use a combination of the employee's first and last name. While the exact structure can vary, a likely pattern is the first initial followed by the last name, or first name separated from the last name by a dot.
A common pattern is `[first_initial][last]@peel-therapeutics.com` (e.g., jdoe@peel-therapeutics.com).
Format
jschiffman@peel-therapeutics.com
Example
85%
Success rate
peel-therapeutics.com • June 20, 2023
Peel Therapeutics reported that the first patient has been dosed in its Phase 1 clinical study of PEEL-224. PEEL-224 is an investigational therapy being evaluated for patients with advanced solid tumors, representing a key milestone for the company's clinical development pipeline....more
peel-therapeutics.com • November 18, 2020
Peel Therapeutics announced its official launch along with $22.7 million in Series A financing. The funding, led by Artis Ventures, was designated to advance the company's development of cancer therapies derived from natural evolutionary processes and molecules....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Peel Therapeutics, are just a search away.